Significats de anti-ccp positivity en anglès

Objective: To investigate short-term and long-term direct health care expenditures associated with anti-CCP positivity in newly diagnosed RA patients.

Conclusions: In newly diagnosed RA patients, higher economic burden associated with anti-CCP positivity was mainly driven by prescription costs.

The baseline differences between anti-CCP positivity and negativity and differences in censoring during follow-up were addressed using propensity scores.

Total additional burden associated with anti-CCP positivity during the first 4 years was estimated to be $14,089 per patient.